[1]
G. Pittari, D. Costi, and M. Raballo, et al., “Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma”, Acta Biomed, vol. 77, no. 2, pp. 81–84, Aug. 2006, Accessed: Jul. 28, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1990